Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Opinion on Biological Therapy
List of Issues
Volume 21, Issue 4

Expert Opinion on Biological Therapy

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Biological Therapy, Volume 21, Issue 4 (2021)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Biological Therapy, Volume 21, Issue 4 (2021)

See all volumes and issues

Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Volume 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Tocilizumab for the treatment of COVID-19

Mario Fernández-Ruiz, Francisco López-Medrano & José María Aguado

Pages: 431-434

Published online: 27 Jan 2021

First Page PreviewforTocilizumab for the treatment of COVID-19 | Full Text | References | PDF (279.3 KB) | EPUB

3938 Views
0 CrossRef citations
0Altmetric

Free Access

Drug Profile

Article

Brexucabtagene autoleucel for the treatment of relapsed/refractory mantle cell lymphoma

Agrima Mian & Brian T. Hill

Pages: 435-441

Published online: 11 Mar 2021

AbstractforBrexucabtagene autoleucel for the treatment of relapsed/refractory mantle cell lymphoma | Full Text | References | PDF (2 MB) | EPUB

818 Views
35 CrossRef citations
0Altmetric

Article

The evolving role of rituximab in the treatment of pemphigus vulgaris: a comprehensive state-of-the-art review

Khalaf Kridin & A. Razzaque Ahmed

Pages: 443-454

Published online: 08 Mar 2021

AbstractforThe evolving role of rituximab in the treatment of pemphigus vulgaris: a comprehensive state-of-the-art review | Full Text | References | PDF (391.8 KB) | EPUB

263 Views
5 CrossRef citations
0Altmetric

Article

Tafasitamab for the treatment of relapsed or refractory diffuse large B-cell lymphoma

Gilles Salles, Monika Długosz-Danecka, Hervé Ghesquières & Wojciech Jurczak

Pages: 455-463

Published online: 15 Feb 2021

AbstractforTafasitamab for the treatment of relapsed or refractory diffuse large B-cell lymphoma | Full Text | References | PDF (502.6 KB) | EPUB

6775 Views
17 CrossRef citations
0Altmetric

Open Access

Review

Bioengineering lungs — current status and future prospects

Vishal Swaminathan, Barry R. Bryant, Vakhtang Tchantchaleishvili & Taufiek Konrad Rajab

Pages: 465-471

Published online: 19 Oct 2020

AbstractforBioengineering lungs — current status and future prospects | Full Text | References | PDF (303.2 KB) | EPUB

207 Views
4 CrossRef citations
0Altmetric

Mesothelin-targeted CAR-T cell therapy for solid tumors

Astero Klampatsa, Vivian Dimou & Steven M. Albelda

Pages: 473-486

Published online: 12 Nov 2020

AbstractforMesothelin-targeted CAR-T cell therapy for solid tumors | Full Text | References | PDF (2 MB) | EPUB

20816 Views
2 CrossRef citations
0Altmetric

Open Access

Practical management of adverse events in patients with advanced systemic mastocytosis receiving midostaurin

Jason Gotlib, Hanneke C. Kluin-Nelemans, Cem Akin, Karin Hartmann, Peter Valent & Andreas Reiter

Pages: 487-498

Published online: 15 Jan 2021

AbstractforPractical management of adverse events in patients with advanced systemic mastocytosis receiving midostaurin | Full Text | References | PDF (1.2 MB) | EPUB

443 Views
5 CrossRef citations
0Altmetric

Self-administration of omalizumab: why not? A literature review and expert opinion

Francesco Menzella, Emanuele Ferrari, Silvia Mariel Ferrucci, Enrico Lombardi, Silvio Alfano, Ornella Bonavita, Paolo Morini, Andrea Rizzi & Andrea Matucci

Pages: 499-507

Published online: 13 Feb 2021

AbstractforSelf-administration of omalizumab: why not? A literature review and expert opinion | Full Text | References | PDF (1.5 MB) | EPUB

3650 Views
10 CrossRef citations
0Altmetric

Open Access

Anticalin® proteins: from bench to bedside

Friedrich-Christian Deuschle, Elena Ilyukhina & Arne Skerra

Pages: 509-518

Published online: 01 Nov 2020

AbstractforAnticalin® proteins: from bench to bedside | Full Text | References | PDF (3.4 MB) | EPUB

501 Views
19 CrossRef citations
0Altmetric

Anti-IFNαR Mabs for the treatment of systemic lupus erythematosus

Bethan Goulden & David Isenberg

Pages: 519-528

Published online: 30 Oct 2020

AbstractforAnti-IFNαR Mabs for the treatment of systemic lupus erythematosus | Full Text | References | PDF (338 KB) | EPUB

291 Views
8 CrossRef citations
0Altmetric

Gene therapy for primary immunodeficiencies: up-to-date

Kritika Chetty & Claire Booth

Pages: 529-538

Published online: 29 Oct 2020

AbstractforGene therapy for primary immunodeficiencies: up-to-date | Full Text | References | PDF (905.6 KB) | EPUB

343 Views
3 CrossRef citations
0Altmetric

Original Research

Article

Advances in the optimization of therapeutic drug monitoring using serum, tissue and faecal anti-tumour necrosis factor concentration in patients with inflammatory bowel disease treated with TNF-α antagonists

Kata Judit Szántó, Tamara Madácsy, Diána Kata, Tamás Ferenci, Mariann Rutka, Anita Bálint, Renáta Bor, Anna Fábián, Ágnes Milassin, Boldizsár Jójárt, Zoltán Szepes, Ferenc Nagy, Tamás Molnár, Imre Földesi, József Maléth & Klaudia Farkas

Pages: 539-548

Published online: 07 Mar 2021

AbstractforAdvances in the optimization of therapeutic drug monitoring using serum, tissue and faecal anti-tumour necrosis factor concentration in patients with inflammatory bowel disease treated with TNF-α antagonists | Full Text | References | PDF (4 MB) | EPUB | Supplemental

217 Views
4 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Overview of biosimilar medicines in Spain: market dynamics, policies, evidence-based insights and avenues for a sustainable market

Isabel Río-Álvarez et al.

Review Article | Published online: 6 Jun 2024

Non-TNF biologics and their biosimilars in rheumatoid arthritis

Tsz Ching Mok et al.

Review Article | Published online: 22 May 2024

Relative bioavailability, immunogenicity, and safety of two adalimumab-adbm formulations in healthy volunteers: a double-blind, randomized, single-dose, parallel-arm Phase I trial (VOLTAIRE-HCLF)

Viktoria Moschetti et al.

Article | Published online: 19 May 2024

Open Access

Randomized, double-blind, placebo-controlled, multicenter study to evaluate efficacy and safety of the denosumab biosimilar MW031 in Chinese postmenopausal women with osteoporosis

Yan Jiang et al.

Article | Published online: 16 May 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Biological Therapy (Vol.21, Iss.4, 2021)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?